S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% BITCOIN 64,419.04 -0.58%
Next Bullish Trade
Sign in
BSX

Boston Scientific Corporation BSX

$44.03 -0.59 (-1.32%)
Pullback · -0.61σ

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · BSX

Momentum reads · latest daily bar
Last
$44.03
-0.59 (-1.32%)
Mkt cap
$65.4B
Healthcare
RSI(14)
41.9
neutral
Stochastic %K
40.7
neutral
MFI(14)
46.3
neutral
ADX(14)
26.9
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $5.2B $1.3B $1.1B $0.2B 25.8% 20.6%
2025-12-31 $5.3B $0.7B $1.0B $0.9B 12.7% 19.7%
2025-09-30 $5.1B $0.8B $1.1B $1.1B 14.9% 20.7%
2025-06-30 $5.1B $0.8B $0.9B $1.1B 15.7% 18.6%
2025-03-31 $4.7B $0.7B $0.9B $0.3B 14.5% 20.1%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare BSX vs peers

Line BSX up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing BSX no peers yet — add up to 4 below

Add tickers to compare with BSX

~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-04-22 0.80 0.79 +1.6% +1.3%
2026-02-04 0.80 0.78 +2.4% +2.8%
2025-10-22 0.75 0.71 +5.1% -1.4%
2025-07-23 0.75 0.73 +3.4% -1.4%
2025-04-23 0.75 0.67 +11.5% +2.2%
2025-02-05 0.70 0.66 +6.6% +0.1%
2024-10-23 0.63 0.59 +7.0% -2.7%
2024-07-24 0.62 0.58 +6.5% -4.5%
2024-04-24 0.56 0.51 +9.1% +0.5%
2024-01-31 0.55 0.51 +7.3% +2.5%
2023-10-26 0.50 0.48 +4.7% -0.5%
2023-07-27 0.53 0.49 +8.2% -1.8%
2023-04-26 0.47 0.43 +8.6% +1.8%
2023-02-01 0.45 0.47 -4.6% +1.1%
2022-10-26 0.43 0.44 -2.6% -0.5%
2022-07-27 0.44 0.42 +4.0% +2.1%
2022-04-27 0.39 0.39 +1.2% -0.8%
2022-02-02 0.45 0.44 +2.5% +2.8%
2021-10-27 0.41 0.40 +3.7% -1.1%
2021-07-27 0.40 0.37 +7.3% -0.2%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
BSX $65B 18.4 11.9 3.2 13.7 2.5 68.9% 11.6% 100.0% 4.29%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0%
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 36.76%

HolderShares% out
Blackrock Inc. 131,822,037 8.87%
Vanguard Capital Management LLC 96,411,568 6.49%
FMR, LLC 74,226,395 4.99%
State Street Corporation 67,986,847 4.57%
JPMORGAN CHASE & CO 33,350,157 2.24%
Geode Capital Management, LLC 33,285,757 2.24%
Primecap Management Company 32,529,774 2.19%
Vanguard Portfolio Management LLC 29,796,211 2.00%
Shaw D.E. & Co., Inc. 24,312,352 1.64%
Bank of America Corporation 22,756,646 1.53%

Insider activity · 90d

11 buys / 0 sells · ratio 11.0 · Finnhub

  • Monson Jonathan M 6,263
  • Monson Jonathan F 39,063 @ $43.06
  • Monson Jonathan M 40,073
  • Mahoney Michael F G 0
  • Pegus Cheryl BUY 1,770 @ $56.49
  • Habiger David C BUY 13,878 @ $55.92
  • LUDWIG EDWARD J BUY 25,359 @ $56.68
  • Habiger David C BUY 11,628 @ $56.95
  • Morano Susan E BUY 11,744
  • Morano Susan E BUY 10,463

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$55.0
Mean
$72.42857
High
$106.0
Analysts
28
Recommendation distribution · period 2026-07-01
12
19
8
Revision trend (2026-04-01 → 2026-07-01): net 38 → 31 -7 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
4 2026-07-02 Insider transaction (Form 4) view ·
4 2026-06-01 Insider transaction (Form 4) view ·
4 2026-05-21 Insider transaction (Form 4) view ·
4 2026-05-21 Insider transaction (Form 4) view ·
4 2026-05-21 Insider transaction (Form 4) view ·
8-K 2026-05-18 8-K view ·
8-K 2026-05-18 8-K view ·
4 2026-05-11 Insider transaction (Form 4) view ·
4 2026-05-11 Insider transaction (Form 4) view ·
4 2026-05-11 Insider transaction (Form 4) view ·
4 2026-05-11 Insider transaction (Form 4) view ·
4 2026-05-11 Insider transaction (Form 4) view ·
4 2026-05-11 Insider transaction (Form 4) view ·
4 2026-05-11 Insider transaction (Form 4) view ·
4 2026-05-11 Insider transaction (Form 4) view ·
4 2026-05-11 Insider transaction (Form 4) view ·
8-K 2026-05-05 8-K view ·
4 2026-05-04 Insider transaction (Form 4) view ·
4 2026-05-04 Insider transaction (Form 4) view ·
10-Q 2026-05-01 10-Q view ·
8-K 2026-04-22 8-K view ·
8-K 2026-03-30 8-K view ·
DEF 14A 2026-03-18 DEF 14A view ·
4 2026-03-04 Insider transaction (Form 4) view ·
4 2026-03-04 Insider transaction (Form 4) view ·
4 2026-03-04 Insider transaction (Form 4) view ·
4 2026-03-04 Insider transaction (Form 4) view ·
4 2026-03-03 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·
8-K 2026-02-26 8-K view ·
8-K 2026-02-23 8-K view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-17 Insider transaction (Form 4) view ·
4 2026-02-17 Insider transaction (Form 4) view ·
4 2026-02-17 Insider transaction (Form 4) view ·
4 2026-02-17 Insider transaction (Form 4) view ·
4 2026-02-17 Insider transaction (Form 4) view ·
4 2026-02-17 Insider transaction (Form 4) view ·
4 2026-02-17 Insider transaction (Form 4) view ·
4 2026-02-17 Insider transaction (Form 4) view ·
10-K 2026-02-17 10-K view ·
8-K 2026-02-05 8-K view ·
8-K 2026-02-04 8-K view ·
4 2026-02-03 Insider transaction (Form 4) view ·
8-K 2026-01-15 CURRENT REPORT view ·
8-K 2026-01-15 CURRENT REPORT view ·
4 2025-12-02 Insider transaction (Form 4) view ·
4 2025-12-01 Insider transaction (Form 4) view ·
8-K 2025-11-19 8-K view ·
4 2025-11-14 Insider transaction (Form 4) view ·
4 2025-11-06 Insider transaction (Form 4) view ·
4 2025-11-04 Insider transaction (Form 4) view ·
10-Q 2025-11-03 10-Q view ·

About BSX

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides tec…

Options picks · BSX

ITM + OTM ideas from the latest scan

Loading…

Congress trades · BSX

STOCK Act disclosures

Loading…

SEC filings & insiders · BSX

EDGAR · live

Loading…

Holders · BSX

Institutions & insider activity

Loading…